ImmuCell Corporation ICCC

9.93 (0.04) (0.40%) as of 25 Sep
Market cap
$90.6M
P/E
117×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
10.62 3.80 2.52 8.77 7.95 10.19 5.79 0.98 3.76 3.81
Receivables
0.99 1.34 0.93 1.64 1.80 2.69 1.76 2.19 3.77 3.42
Inventory
2.13 2.05 2.33 2.52 2.09 3.09 6.04 7.81 7.11 9.27
Total current assets
14.35 7.51 6.42 13.19 12.16 16.26 13.99 11.47 15.04 16.94
Property, Plant, Equpment (Net)
9.85 26.07 26.03 25.27 26.76 26.89 28.44 27.58 25.35 21.07
Long-Term Investments
— — 0.04 — — — — — — —
Goodwill and Intangible Assets (Total)
0.27 0.25 0.23 0.21 0.19 0.17 0.15 0.13 0.11 0.10
Long Term Assets (Tax, Deferred)
0.20 0.47 — — — — — — — —
Long-term assets (Other)
0.03 0.00 0.05 0.03 0.03 0.03 0.08 0.06 0.03 0.04
Total non-current assets
10.35 26.79 26.31 25.50 28.19 28.20 30.87 32.34 30.06 25.59
Total Assets
24.70 34.30 32.73 38.69 40.35 44.47 44.86 43.81 45.10 42.53
Accounts Payable
1.89 1.72 1.22 1.22 1.35 1.61 2.00 2.12 2.48 2.28
Current Part of Debt
0.13 0.32 1.34 1.27 0.76 0.81 1.04 1.43 1.50 1.61
Current Revenue (Deferred)
0.03 0.02 0.00 — — — — — — —
Total current liabilities
2.06 2.06 2.57 2.50 2.21 2.53 3.07 4.20 4.41 3.98
Long Term Debt (Total)
2.88 8.64 8.42 7.15 8.74 8.33 9.19 10.54 9.04 7.49
Non-current Liabilities (Other)
0.04 0.00 0.00 0.06 0.00 — — — — —
Total non-current liabilities
2.92 8.64 8.42 7.21 9.87 9.35 11.41 14.62 13.17 11.50
Total liabilities
4.98 10.70 10.99 9.70 12.08 11.89 14.48 18.82 17.58 15.48
Additional Paid In Capital
18.53 22.46 22.70 31.13 31.37 35.69 35.98 36.36 40.92 41.48
Common Stock (Net)
0.50 0.57 0.57 0.73 0.73 0.78 0.78 0.78 0.90 0.91
Retained Earnings
1.15 0.98 (1.34) (2.64) (3.66) (3.74) (6.23) (12.01) (14.16) (15.20)
Treasury Stock
0.43 0.41 0.20 0.19 0.18 0.16 0.15 0.14 0.14 0.13
Common Equity (Total)
19.72 23.59 21.74 28.99 28.27 32.58 30.38 24.99 27.52 27.06
Shareholders Equity (Total)
19.72 23.59 21.74 28.99 28.27 32.58 30.38 24.99 27.52 27.06
Shareholders Equity and Liabilities (Total)
24.70 34.30 32.73 38.69 40.35 44.47 44.86 43.81 45.10 42.53
Shares (Common)
4.85 5.48 5.57 7.21 7.22 7.74 7.75 7.75 8.98 9.05
Shareholders Equity (Tangible)
19.45 23.35 21.52 28.78 28.08 32.41 30.23 24.86 27.40 26.96
Net Debt
(7.61) 5.16 7.24 (0.35) 1.55 (1.05) 4.44 10.99 6.78 5.29
Total Debt
3.01 8.96 9.77 8.42 9.50 9.14 10.23 11.97 10.54 9.10

Fold the line items

In millions of $ except per-share values · columns are period end dates